Molecular basis of sickle cell-endothelial cell interactions

Current Opinion in Hematology

Volumn 3, Issue 2, 1996, Pages 118-124

  Wick, Timothy M ^a   Eckman, James R ^b  

^a Georgia Institute of Technology   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CYTOKINE; FIBRONECTIN; GLYCOPROTEIN IB; INTEGRIN; INTERLEUKIN 8; PHORBOL ESTER; THROMBOSPONDIN; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

CELL INTERACTION; ENDOTHELIUM CELL; ERYTHROCYTE ADHESIVENESS; GENE EXPRESSION; HEMODYNAMICS; HUMAN; PAIN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RETICULOCYTE; REVIEW; SHEAR STRESS; SICKLE CELL; VASCULAR ENDOTHELIUM;

EID: 0029892514     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199603020-00003     Document Type: Review

References (70)

1. Hoover R, Rubin R, Wise G, Warren R: Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures. Blood 1979, 54:872-876. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
2. Hebbel RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW: Abnormal adherence of sickle erythrocytes to cultured vascular endothelium. Possible mechanism for microvascular occlusion. J Clin Invest 1980, 65:154-160. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
3. Church S, Lubin B, Reid CD: Management and Therapy of Sickle Cell Disease. Washington, DC: US Department of Health and Human Services, Public Health Service, National Institutes of Health. NIH Publication No. 91-2117; 1991:15-21.
4. Platt AF, Eckman JR: The multidisciplinary management of pain in patients with sickle cell syndromes. J Am Acad Phys Assist 1989, 2:104-113.
5. Hofrichter J, Ross PD, Eaton WA: Supersaturation of sickle cell hemoglobin solutions. Proc Natl Acad Sci U S A 1976, 73:3035-3039.
6. Mozzarelli A, Hofrichter J, Eaton WA: Delay times of hemoglobin S gelation prevent most cells from sickling in vivo. Science 1987, 237:500-506.
7. Kaul DK, Fabry ME, Nagel RL: Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications. Proc Natl Acad Sci U S A 1989, 86:3356-3360. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
8. Brittain HA, Eckman JR, Wick TM: Sickle erythrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different. J Lab Clin Med 1992, 120:538-545. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
9. Hebbel RP, Moldow CF, Steinberg MH: Modulation of erythrocyte-endothelial interactions and the vasoocclusive severity of sickling disorders. Blood 1981, 58:947-952. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
10. Mohandas N, Evans E: Adherence of sickle erythrocytes to vascular endothelial cells: requirement for both cell membrane changes and plasma factors. Blood 1984, 64:282-287. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
11. Hebbel RP, Eaton JW, Steinberg MH, White JG: Erythrocyte/endothelial interactions in the pathogenesis of sickle-cell disease: a "real logical" assessment. Blood Cells 1982, 8:163-173. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
12. Weinstein R, Zhou M, Bartlett-Pandite A, Wenc K: Sickle erythrocytes inhibit human endothelial DNA synthesis. Blood 1990, 76:2146-2152. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
13. Antonucci R, Walker R, Herion J, Orringer E: Enhancement of sickle erythrocyte adherence to endothelium by autologous platelets. Am J Hematol 1990, 34:44-48. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
14. Mohandas N, Evans E: Sickle erythrocyte adherence to endothelium. Morphologic correlates and the requirement for divalent cations and collagen-binding plasma proteins. J Clin Invest 1985, 76:1605-1612. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
15. Wautier JL, Pintigny D, Wautier MP, Paton RC, Galacteros F, Passa P, Caen JP: Fibrinogen, a modulator of erythrocyte adhesion to vascular endothelium. J Lab Clin Med 1963, 101:911-920. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
16. Wick TM, Moake JL, Udden MM, Eskin SG, Sears DA, McIntire LV: Unusually large von Willebrand factor multiers increase adhesion of sickle erythrocytes to endothelial cells under controlled flow. J Clin Invest 1907, 80:905-910. Provides mechanistic data on the four adherence pathways described in this review.
17. Patel VP, Ciechanover A, Platt O, Lodish HF: Mammalian reticulocytes lose adhesion to fibronectin during maturation to erythrocytes. Proc Natl Acad Sci U S A 1985, 82:440-444. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
18. Wick TM, Moake JL, Udden MM, McIntire LV: Unusually large von Willebrand factor multimers preferentially promote young sickle and non-sickle erythrocyte adhesion to endothelial cells. Am J Hematol 1993, 42:284-292. Provides mechanistic data on the four adherence pathways described in this review.
19. Kaul DK, Nagel RL, Chen D, Tsai HM: Sickle erythrocyte-endothelial interactions in microcirculation: the role of von Willebrand factor and implication for vasoocclusion. Blood 1993, 81:2429-2438. Provides mechanistic data on the four adherence pathways described in this review.
20. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM: Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood 1993, 81:2137-2143. Provides mechanistic data on the four adherence pathways described in this review.
21. + sickle reticulocytes to endothelial cells. Blood 1992, 80:2634-2642. Provides mechanistic data on the four adherence pathways described in this review.
22. Lipowsky HH, Usami S, Chien S: Human SS red blood cell rheological behavior in the microcirculation of cremaster muscle. Blood Cells 1982, 6:113-126. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
23. Baez S, Kaul DK, Nagel RL: Microvascular determinants of blood flow behavior and HbSS erythrocyte plugging in microcirculation. Blood Cells 1982, 8:127-137. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
24. Barabino GA, McIntire LV, Eskin SG, Sears DA, Udden M: Endothelial cell interactions with sickle cell, sickle trait mechanically injured, and normal erythrocytes under controlled flow. Blood 1987, 70:152-157. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
25. Grabowski EF: Sickle erythrocytes adhere to endothelial cell monolayers exposed to flow. Prog Clin Biol Med 1987, 240:167-179. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
26. Ruggeri ZM, Ware J: von Willebrand factor. FASEB J 1993, 7:308-316.
27. 1 dependent mechanism. Blood 1993, 82:1891-1899. Provides mechanistic data on the four adherence pathways described in this review.
28. 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood 1993, 82:3548-3555. Provides mechanistic data on the four adherence pathways described in this review.
29. Swerlick RA, Lee K, Wick TM, Lawley TJ: Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 1992, 48:78-83.
30. Switalska HI, Niewiarowski S, Tuszynski GP, Rucinski B, Schmaier AH, Morinelli TA: Radioimmunoassay of human platelet thrombospondin: different patterns of thrombospondin and β-thromboglobulin antigen secretion and clearance from the circulation. J Lab Clin Med 1985, 106:690-700.
31. Swerlick RA, Brown EJ, Xu Y, Lee KH, Manos S, Lawley TJ: Expression and modulation of the vitronectin receptor on human dermal microvascular endothelial cells. J Invest Dermatol 1992, 99:715-722.
32. Lawler J, Hynes RO: An integrin receptor from normal and thrombasthenic platelets that binds thrombospondin. Blood 1989, 74:2022-2027.
33. Leung LKL, Li W-X, McGregor JL, Albrecht G, Howard RJ: CD36 peptides enhance or inhibit CD36 thrombospondin binding. J Biol Chem 1992, 267:18244-18250.
34. 3 integrin) in human endothelial cells. J Biol Chem 1991, 266:7638-7645.
35. Asch AS, Silbiger S, Heimer E, Nachman RL: Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biophys Biochem Res Comm 1992, 182:1208.
36. van Schravendijk MR, Handunnetti SM, Barnwell JW, Howard RJ: Normal human erythrocytes express CD36, an adhesion molecule of monocytes, platelets, and endothelial cells. Blood 1992, 80:2105-2114.
37. Gee BE, Platt OS: Sickle reticulocytes adhere to VCAM-1. Blood 1995, 85:268-274. Provides mechanistic data on the four adherence pathways described in this review.
38. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990, 60:579-584.
39. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosa G, Lobb R: Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989, 59:1203-1217.
40. Swerlick RA, Lee KH, Li L-J, Sepp NT, Caughman SW, Lawley TJ: Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J Immunol 1992, 149:698-705.
41. Diggs LW: Sickle cell crisis. Am J Clin Pathol 1965, 44:1-19.
42. Yang J, Xu Y, Zhu C, Hagan MK, Lawley T, Offermann MK: Regulation of adhesion molecule expression in Kaposi's sarcoma cells. J Immunol 1994, 152:361-373.
43. Offermann MK, Medford R: Induction of VCAM-1 gene expression by double stranded RNA occurs by a p68 kinase-dependent pathway in endothelial cells [abstract]. Clin Res 1993, 412:262a.
44. Smolinski PA, Offermann MK, Eckman JR, Wick TM: Synthetic double stranded RNA increases sickle red blood cell adherence to endothelium via a VCAM-1/VLA-4 pathway. Blood 1995, 85:2945-2950. Provides mechanistic data on the four adherence pathways described in this review.
45. Hebbel RP, Visser MR, Goodman JL, Jacob HS, Vercellotti GM: Potentiated adherence of sickle erythrocytes to endothelium infected by virus. J Clin Invest 1987, 80:1503-1506. Provides mechanistic data on the four adherence pathways described in this review.
46. Natarajan M, McIntire LV, Udden M, Moake J: Adhesion of sickle cells and damage to IL-1 stimulated endothelial cells under flow conditions in vitro [abstract]. Ann Biomed Eng 1994, 22:26a. Provides mechanistic data on the four adherence pathways described in this review.
47. Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992, 69:11-25.
48. 1-fibronectin receptors upon B cell activation. Eur J Immunol 1991, 21:2437-2445.
49. Hauzenberger D, Sundqvist KG: Fibronectin at the lymphocyte surface. Evidence for activation-dependent binding to VLA4 and VLA5 integrins. Scand J Immunol 1993, 37:87-95.
50. Masumoto A, Hemler ME: Multiple activation states of VLA-4. J Biol Chem 1993, 268:228-234.
51. 1 integrin (CD29) stimulates VLA-dependent adherence of leucocytes to human umbilical vein endothelial cells and matrix components. J Cell Biol 1992, 116:499-509.
52. Rot A: Endothelial cell binding of NAP-1/IL8: role in neutrophil emigration. Immunol Today 1992, 13:291-294.
53. 1 integrin on sickle reticulocytes and fibronectin on endothelium [abstract]. Blood 1994, 84:408a Provides mechanistic data on the four adherence pathways described in this review.
54. Butcher EC: Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991, 67:1033-1036.
55. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ: Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other defense cytokines. Proc Natl Acad Sci U S A 1987, 84:9233-9237.
56. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene "intercrine" cytokine family. Ann Rev Immunol 1991, 9:617-648.
57. Darbonne WC, Rice GC, Mohler MA, Apple T, Hébert CA, Valente AJ, Baker JB: Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991, 88:1362.
58. Wautier JL, Wautier MP, Pintigny D, Galacteros F, Courillon A, Passa P, Caen JP: Factors involved in cell adhesion to endothelium. Blood Cells 1983, 9:221-234. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-ocdusive pain episodes.
59. Wautier JL, Galacteros F, Wautier MP, Pintigny D, Beuzard Y, Rosa J, Caen JP: Clinical manifestations and erythrocyte adhesion to endothelium in sickle cell syndrome. Am J Hematol 1985, 19:121-130. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
60. Wautier JL, Pintigny D, Maclouf J, Wautier MP, Corvazier E, Caen J: Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium. J Lab Clin Med 1986, 107:210-215. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
61. Vordermeier S, Singh S, Biggerstaff J, Harrison P, Grech H, Pearson TC, Dumonde DC, Brown KA: Red blood cells from patients with sickle cell disease exhibit an increased adherence to cultured endothelium pretreated with tumor necrosis factor (TNF). Br J Haematol 1992, 81:591-597. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
62. Smith BO, LaCelle PL: Erythrocyte-endothelial cell adherence in sickle cell disorders. Blood 1986, 68:1050-1054. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
63. Burns ER, Wilkinson WH, Nagel RL: Adherence properties of sickle erythrocytes in dynamic flow systems. J Lab Clin Med 1985, 105:673-678. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
64. Kucukcelebi A, Barmatoski SP, Barnhart MI: Interactions between vessel wall and perfused sickle erythrocytes: preliminary observations. Scanning Microsc 1980, 3:243-248. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
65. Baez S, Kaul DK, Nagel RL: Microvascular determinants of blood flow behavior and HbSS erythrocyte plugging in microcirculation. Blood Cells 1982, 8:127-137. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
66. Kaul DK, Fabry ME, Nagel RL: Vaso-occlusion by sickle cells: evidence for selective trapping of dense cells. Blood 1986, 68:1162-1166. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
67. Fabry ME, Rajanayagam V, Fine E, Holland S, Gore JC, Nagel RL, Kaul DK: Modeling sickle cell vasoocclusion in the rat leg: quantification of trapped sickle cells and correlation with 31P metabolic and 1H magnetic resonance imaging. Proc Natl Acad Sci U S A 1969, 86:3808-3812. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
68. Fabry ME, Fine E, Rajanayagam V, Factor SM, Gore J, Sylla M, Nagel RL: Demonstration of endothelial adhesion of sickle cells in vivo: a distinct role for deformable discocytes. Blood 1992, 79:1602-1611. Provides additional details about the role of sickle cell-endothelial cell adherence in the pathophysiology of sickle cell vaso-occlusive pain episodes.
69. Hebbel RP: Beyond hemoglobin polymerization: the red blood cell membrane and sickle cell disease pathophysiology. Blood 1991, 77:214-237.
70. Hebbel RP, Ney PA, Foker W: Automation, dehydration, and adhesivity may be related abnormalities of sickle erythrocytes. Am J Physiol 1989, 256:C579-C583.